PMAIP1 and cancer: In this context, Noxa antagonizes the function of Mcl-1, and therefore high levels of Noxa render cancer cells susceptible to BH3 mimetics, such as ABT263 and ABT199, also known as navitoclax and venetoclax, respectively (14–16).